Lataa...
Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection
Hepatitis C virus (HCV) is a leading cause of cirrhosis and hepatocellular carcinoma (HCC) in the US and Japan. Therefore, eradication of HCV may reduce the occurrence of HCC in HCV-infected individuals. In 2011, the use of first-generation HCV NS3/4A protease inhibitors such as telaprevir and bocep...
Tallennettuna:
| Julkaisussa: | J Clin Transl Hepatol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
XIA & HE Publishing Ltd
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4521257/ https://ncbi.nlm.nih.gov/pubmed/26356295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2013.00025 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|